Abstract:Congenital heart disease (CHD) is the most common type of developmental abnormality in humans, and is a leading cause for substantially increased morbidity and mortality in affected individuals. Increasing studies demonstrates a pivotal role of genetic defects in the pathogenesis of CHD, and presently mutations in more than 60 genes have been associated with CHD. Nevertheless, CHD is of pronounced genetic heterogeneity, and the genetic basis underpinning CHD in a large proportion of patients remains unclear. In the present study, the whole coding exons and splicing donors/acceptors of the MEF2C gene, which codes for a transcription factor essential for normal cardiovascular development, were sequenced in 200 unrelated patients affected with CHD, and a novel heterozygous missense mutation, p.L38P, was identified in an index patient with patent ductus arteriosus (PDA) and ventricular septal defect (VSD). Genetic scan of the mutation carrier's family members available showed that the mutation was present in all affected family members but absent in unaffected family members. Analysis of the proband's pedigree revealed that the mutation co-segregated with PDA, which was transmitted as an autosomal dominant trait with complete penetrance. The mutation changed the amino acid that was completely conserved evolutionarily, and did not exist in 300 unrelated, ethnically-matched healthy individuals used as controls. Functional deciphers by using a dual-luciferase reporter assay system unveiled that the mutant MEF2C protein had a significantly reduced transcriptional activity. Furthermore, the mutation significantly diminished the synergistic activation between MEF2C and GATA4, another cardiac core transcription factor that has been causally linked to CHD. In conclusion, this is the first report on the association of a MEF2C loss-of-function mutation with an increased vulnerability to CHD in humans, which provides novel insight into the molecular mechanisms underlying CHD, implying potential implications for early diagnosis and timely prophylaxis of CHD.

KLF13 Loss-of-function Variation Contributes to Familial Congenital Heart Defects

Identification and Analysis of KLF13 Variants in Patients with Congenital Heart Disease

A Novel KLF13 Mutation Underlying Congenital Patent Ductus Arteriosus and Ventricular Septal Defect, As Well As Bicuspid Aortic Valve.

SOX7 loss-of-function variation as a cause of familial congenital heart disease

KLF15 Loss-of-Function Mutation Underlying Atrial Fibrillation As Well As Ventricular Arrhythmias and Cardiomyopathy

Identification of <i>SOX18</i> as a New Gene Predisposing to Congenital Heart Disease

Association of NKX2-5 Gene with Congenital Heart Disease

SMAD1 Loss-of-Function Variant Responsible for Congenital Heart Disease

GW24-e3589 A novel mutation 1587_1588 del2 of the low-density lipoprotein receptor gene associated with familial hypercholesterolemia in a Chinese family

Prenatal Genetic Diagnosis in Three Fetuses With Left Heart Hypoplasia (LHH) From Three Unrelated Families

A HAND2 Loss-of-Function Mutation Causes Familial Ventricular Septal Defect and Pulmonary Stenosis

A Novel NKX2-5 Mutation in Familial Ventricular Septal Defect.

Multiple gene variations contributed to congenital heart disease via GATA family transcriptional regulation

A Novel MEF2C Loss-of-Function Mutation Associated with Congenital Double Outlet Right Ventricle

Identification and Functional Characterization of KLF5 As a Novel Disease Gene Responsible for Familial Dilated Cardiomyopathy.

ISL1 Loss-of-function Mutation Contributes to Congenital Heart Defects

Association of Functional Variant in GDF1 Promoter with Risk of Congenital Heart Disease and Its Regulation by Nkx2.5

MEF2C Loss-of-function Mutation Contributes to Congenital Heart Defects.

Uncovering the Rare Variants of Dlc1 Isoform 1 and Their Functional Effects in A Chinese Sporadic Congenital Heart Disease Cohort

A Novel Nkx2.6 Mutation Associated with Congenital Ventricular Septal Defect

Analysis of the CHD7 Gene Mutations in Patients of Congenital Heart Disease with Extracardiac Malformations